Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria

Authors:

Abstract
We determined pretreatment and acquired human immunodeficiency virus (HIV) drug resistance among children with HIV type 1 (HIV-1) in Jos, Nigeria. The majority (71%) of those who failed first-line antiretroviral therapy were on a nevirapine-containing regimen. The prevalence of pretreatment (48%) and acquired (76%) HIV drug resistance mutations was high in our study. Wider access to HIV drug resistance testing after treatment failure is necessary to optimize second-line treatment options among children with HIV in Nigeria.
Funding Information
  • STAMINA
  • Fogarty International Center
  • Office of the Director
  • National Institute of Neurological Disorders and Stroke
  • National Institute of Nursing Research
  • National Institutes of Health (D43 TW010130)
  • US Department of Health and Human Services
  • Health Resources and Services Administration (U51HA02522- 01-01)
  • Centers for Disease Control and Prevention (PS 001058)

This publication has 15 references indexed in Scilit: